Search research articles
Contact Us
Filters
Showing results (51-60 of 145) with videos related to
Page
of 15
Sort By:
BDJ Open
|
August 14, 2023
Edoxaban use in the context of dental procedures: analysis from the EMIT-AF/VTE database
Cathy Chen, Manish Saxena, Christian von Heymann, et al.
Clinical Cardiology
|
May 15, 2020
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE study
Paolo Colonna, Christian von Heymann, Amparo Santamaria, et al.
British Journal of Clinical Pharmacology
|
December 16, 2021
Improving appropriate use of anticoagulants in hospitalised patients: A pharmacist-led Check of Medication Appropriateness intervention
Charlotte Quintens, Peter Verhamme, Thomas Vanassche, et al.
Journal of the American Heart Association
|
March 26, 2018
Relation of Insulin Resistance to Longitudinal Changes in Left Ventricular Structure and Function in a General Population
Nicholas Cauwenberghs, Judita Knez, Lutgarde Thijs, et al.
Journal of Thrombosis and Thrombolysis
|
January 18, 2023
Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis
Marco Zuin, Stefano Barco, George Giannakoulas, et al.
Thrombosis Journal
|
December 15, 2023
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study
Christian von Heymann, Martin Unverdorben, Paolo Colonna, et al.
Thrombosis and Haemostasis
|
April 26, 2013
Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial
Peter Verhamme, Sophie Gunn, Elisabeth Sonesson, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
June 29, 2019
Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial
Vinai C Bhagirath, John W Eikelboom, Jack Hirsh, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 5, 2025
Population pharmacokinetics of edoxaban in geriatric patients with atrial fibrillation
Angela Elma Edwina, Lorenz Van der Linden, Louise Debruyne, et al.
European Heart Journal. Cardiovascular Imaging
|
August 5, 2019
Interplay of cardiac remodelling and myocardial stiffness in hypertensive heart disease: a shear wave imaging study using high-frame rate echocardiography
Marta Cvijic, Stéphanie Bézy, Aniela Petrescu, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 145) with videos related to
Sort By:
Page
of 15
BDJ Open
|
August 14, 2023
Edoxaban use in the context of dental procedures: analysis from the EMIT-AF/VTE database
Cathy Chen, Manish Saxena, Christian von Heymann, et al.
Clinical Cardiology
|
May 15, 2020
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE study
Paolo Colonna, Christian von Heymann, Amparo Santamaria, et al.
British Journal of Clinical Pharmacology
|
December 16, 2021
Improving appropriate use of anticoagulants in hospitalised patients: A pharmacist-led Check of Medication Appropriateness intervention
Charlotte Quintens, Peter Verhamme, Thomas Vanassche, et al.
Journal of the American Heart Association
|
March 26, 2018
Relation of Insulin Resistance to Longitudinal Changes in Left Ventricular Structure and Function in a General Population
Nicholas Cauwenberghs, Judita Knez, Lutgarde Thijs, et al.
Journal of Thrombosis and Thrombolysis
|
January 18, 2023
Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis
Marco Zuin, Stefano Barco, George Giannakoulas, et al.
Thrombosis Journal
|
December 15, 2023
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study
Christian von Heymann, Martin Unverdorben, Paolo Colonna, et al.
Thrombosis and Haemostasis
|
April 26, 2013
Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial
Peter Verhamme, Sophie Gunn, Elisabeth Sonesson, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
June 29, 2019
Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial
Vinai C Bhagirath, John W Eikelboom, Jack Hirsh, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 5, 2025
Population pharmacokinetics of edoxaban in geriatric patients with atrial fibrillation
Angela Elma Edwina, Lorenz Van der Linden, Louise Debruyne, et al.
European Heart Journal. Cardiovascular Imaging
|
August 5, 2019
Interplay of cardiac remodelling and myocardial stiffness in hypertensive heart disease: a shear wave imaging study using high-frame rate echocardiography
Marta Cvijic, Stéphanie Bézy, Aniela Petrescu, et al.
Page
of 15